Status
Conditions
Treatments
About
The study aims to investigate the use of wireless, continuous monitoring in patients at home including the frequency of alarms triggered by abnormal vital parameters and their significance for (re)hospitalisation/Serious Adverse Events(SAE) and/or death within 30 days.
Full description
Acute hospital admissions challenge the capacity of the healthcare system. Readmission is common among patients with chronic medical diseases, and many patients admitted for acute conditions are often subsequently observed at the hospital for hours and often with one overnight stay for observation purposes alone. Recent medico technical research has allowed continuous and wireless monitoring of patients' vital signs in-hospital, but the practice at home remains uninvestigated. However, the technology has the potential to relieve hospital overcrowding by offering continuous and real time analytics of vital signs in high-risk patients at home.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Adult patients (≥18 years) admitted (with at least one night stay) with an acute medical disease and scheduled for discharge to their own homes
Adult patients (≥18 years) who have contacted the EMS and, after assessment by paramedic personnel, not deemed sick enough for immediate hospital admission.
Exclusion criteria
Patients placed on palliative treatment.
Acceptable chronically abnormal vital parameters of SpO2<88%, MAP<70, RR>24, or HR>110.
Allergy to plaster, plastic, or silicone.
A pacemaker or Implantable Cardioverter Defibrillator (ICD) device.
If the patient was deemed not able to open the front door when visited by the investigator.
Inability to give informed consent.
Loading...
Central trial contact
Emilie Sigvardt, MD; Christian Sylvest Meyhoff, MD, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal